| JYSB1600114 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2016-06-15 | | Baxter AG | Certificate Issued | 2017-03-27 | view |
| JYSB2200217 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2022-11-23 | | Takeda Manufacturing Italia SpA;Takeda Manufacturing Austria AG | | | view |
| JYSB2101030 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2021-05-17 | | Csl Behring AG | | | view |
| JYSZ2100513 | 人血白蛋白 | human albumin | Injection | Biological Products | License Renew | 2021-04-26 | | Csl Behring AG | | | view |
| CYSB2400142 | 人血白蛋白 | human albumin | Injection | Biological Products(原15) | Supplementary Application | 2024-06-04 | | Guangdong Wellen Pharmaceutical Co Ltd | | | view |
| JYSB2300049 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2023-03-10 | | Baxalta Us Inc | | | view |
| CYSB2200006 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| JYSB2500048 | 人血白蛋白 | human albumin | Injection | Biological Products(3.4) | Supplementary Application | 2025-02-26 | | Takeda Pharmaceuticals USA Inc;Baxalta Us Inc | | | view |
| CYSB2101112 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2021-07-13 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| JYSB2400219 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2024-09-30 | | Octapharma Pharmazeutika Produktions GmbH | | | view |
| JYSB1400097 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2014-05-08 | | Baxter Healthcare Corp | Certificate Issued | 2014-11-24 | view |
| CYSB2300220 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2023-12-01 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| JYSB2200121 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2022-07-08 | | Takeda Manufacturing Austria AG | | | view |
| JYSB1400168 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2014-08-06 | | Baxter Healthcare Corp;Baxter Healthcare Corporation Drug Delivery Division | Certificate Issued | 2016-06-20 | view |
| CYSB2101029 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2021-04-07 | | Shanxi Kangbao Biological Product Co Ltd | | | view |
| JYSB2200084 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2022-05-11 | | Bio Products Laboratory Ltd | | | view |
| JYSB1400135 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2014-07-15 | | Baxter Healthcare Corp | Certificate Issued | 2015-12-25 | view |
| JYSB2400037 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2024-03-02 | | Takeda Manufacturing Austria AG | | | view |
| JYSB1300169 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2013-08-02 | | Baxter Healthcare Corp | Certificate Issued | 2015-12-25 | view |
| JYSB2100011 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2021-01-08 | | Baxalta Us Inc | Certificate Issued | 2021-03-05 | view |
